Martini Jeffrey S 4
4 · PALVELLA THERAPEUTICS, INC. · Filed Dec 17, 2024
Insider Transaction Report
Form 4
Martini Jeffrey S
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2024-12-13+126,416→ 126,416 totalExercise: $13.60Exp: 2034-12-13→ Common Stock (126,416 underlying)
Footnotes (1)
- [F1]The stock options will vest in equal monthly tranches over 48 months.